Anti-HGFR / c-Met Reference Antibody (emibetuzumab)
产品介绍
Emibetuzumab是一种人源化二价IgG4型单克隆抗体，靶向MET受体。该抗体具有较强的中和活性，促进受体内吞，抑制HGF依赖性与非依赖性的MET通路激活，阻遏肿瘤生长。
产品性质
产品特色
应用案例
Purity:SDS-PAGE
Anti-HGFR / c-Met Reference Antibody (emibetuzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
Purity:SEC-HPLC
The purity of Anti-HGFR / c-Met Reference Antibody (emibetuzumab) is 99.28%, determined by SEC-HPLC.
Bioactivity:ELISA
Immobilized human c MET His at 2 ug/mL can bind Anti-HGFR / c-Met Reference Antibody (emibetuzumab), EC50=0.004797 ug/mL.
存储条件
-25~-15℃保存，有效期1年。
COA
联系我们
